1. Home
  2. MIRM vs MIDD Comparison

MIRM vs MIDD Comparison

Compare MIRM & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

SELL

Current Price

$92.00

Market Cap

7.2B

Sector

Health Care

ML Signal

SELL

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

SELL

Current Price

$134.65

Market Cap

6.1B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
MIRM
MIDD
Founded
2018
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.1B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
MIRM
MIDD
Price
$92.00
$134.65
Analyst Decision
Strong Buy
Buy
Analyst Count
12
11
Target Price
$157.71
★ $159.56
AVG Volume (30 Days)
★ 548.2K
485.1K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.59
N/A
EPS
N/A
★ 0.07
Revenue
$19,138,000.00
★ $3,201,202,000.00
Revenue This Year
$37.65
N/A
Revenue Next Year
$21.04
$4.18
P/E Ratio
★ N/A
$1,943.43
Revenue Growth
N/A
N/A
52 Week Low
$63.23
$102.15
52 Week High
$130.00
$180.13

Technical Indicators

Market Signals
Indicator
MIRM
MIDD
Relative Strength Index (RSI) 52.45 72.68
Support Level $87.38 $128.09
Resistance Level $98.34 $139.70
Average True Range (ATR) 4.20 4.25
MACD 0.35 0.65
Stochastic Oscillator 48.74 74.78

Price Performance

Historical Comparison
MIRM
MIDD

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in the foodservice industry. The company develops and manufactures a broad line of solutions used in commercial foodservice and food processing. The group showcases its solutions in the Middleby Innovation Kitchens for commercial foodservice and industrial baking and protein Innovation Centers for food processing solutions.

Share on Social Networks: